On average, 25% of macrophage-associated conidia are phagocytosed after 1 h, 16% of these cell-associated conidia are killed after

4 h and conidial germination was inhibited in more than 95% of the conidia of A. fumigatus.[53] Comparable studies on zygomycetes would gain insights into the clearance of the fungal burden and forecast the potential of zygomycetes as causative agents of emerging fungal diseases. Moreover, transcriptomic analysis will help to understand the virulence and survival mechanism of the fungi when it confronts macrophages, e.g. the role of chromatin MI-503 remodelling as a central regulator of survival strategies which facilitates a reprogramming of cellular energy metabolism in macrophage-internalised fungal cells and provide protection against DNA damage as shown for Candida glabrata.[54] Many studies have established that virulence factors can be differentially expressed as a function of experimental conditions,

but clinical isolates of Cryptococcus neoformans behave differently under the same experimental conditions, a diversity that could participate in the variable outcome of infection in humans.[55] It has been hypothesised that the survival strategies for soil-borne, potentially human pathogenic fungi (e.g. C. neoformans) after ingestion by macrophages and amoebae were similar.[56] Consequently, check details it will be worthwhile to compare the mechanisms of phagocytosis with amoebae which served as interacting partners in the environment resulting in a training of the fungal pathogen to successfully cope with the amoeboid immune cells of the human immune system towards adaption to the human host during evolution. Just recently, the whole genome of Acanthamoeba castellanii (Ac) was determined, the first representative from a solitary free-living amoebozoan.[57] Ac utilises a diverse repertoire of predicted

pattern recognition receptors, many with predicted orthologous functions in the innate immune systems of higher organisms.[57] The exploration of the Tacrolimus (FK506) connection between both, receptors of amoebae and immune cells will shed light into the evolutionary origin of the interplay between fungal pathogen and innate immune cells. This work was financially supported by the Deutsche Forschungsgemeinschaft (DFG) Jena School for Microbial Communication (JMRC project #66) and within CRC/TR 124 FungiNet: project Z1 to KV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We express our gratitude to Paul M. Kirk (Royal Botanic Gardens Kew, UK) for providing the numbers of species for the subphyla and orders of the zygomycetes. The authors declare that no conflict of interest exists. “
“This multicentre observational study evaluated the feasibility, efficacy and toxicity of antifungal combination therapy (combo) as treatment of proven or probable invasive fungal diseases (IFDs) in patients with haematological malignancies.